The latest Investing Matters Podcast with Jean Roche, Co-Manager of Schroder UK Mid Cap Investment Trust has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksXPD.L Regulatory News (XPD)

  • There is currently no data for XPD

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Launch of CSOP and Issue of awards to Director

5 Feb 2021 07:00

RNS Number : 0839O
Xpediator PLC
05 February 2021
 

5 February 2021

XPEDIATOR PLC

 

("Xpediator" or the "Company" or the "Group")

 

Launch of CSOP and Issue of awards to Director

 

Xpediator today announces the launch of a new Company Share Option Plan ("CSOP") to employees including, Robert Ross, Chief Executive Officer.

 

The Company has today granted options over 3,168,539 new ordinary shares to 108 employees under the Group CSOP. The award value is between £5,000 - £30,000 (depending on seniority within the business) divided by closing share price on the day before grant of CSOP options with an exercise price equivalent to 110% of the closing share price on the day before grant. These options vest three years from the award date and are subject to meeting a performance criteria of an average earnings per share (EPS) growth of 10% per annum, from the 1st January 2021 to 31st December 2023.

 

Robert Ross has also been granted options over 67,415 new ordinary shares under the CSOP. These options vest three years from the award date and are subject to meeting a performance criteria of an average earnings per share (EPS) growth of 10% per annum, from the 1st January 2021 to 31st December 2023.

 

 

Enquiries

Xpediator plc

 

Robert Ross, CEO

Tel: +44 (0)330 043 239

 

 

Cenkos Securities plc (Nominated Adviser & Joint Broker)

Tel: +44 (0)20 7397 8900

Max Hartley, Max Gould (Corporate Finance)

 

Nick Searle (Sales)

 

Novella Communications (Financial Public Relations)

Tel: +44 (0)20 3151 7008

Tim Robertson

 

Fergus Young

 

 

The following notifications are intended to satisfy the Company's obligations under Article 19(3) of the Market Abuse Regulation.

NOTIFICATION AND PUBLIC DISCLOSURE OF TRANSACTIONS BY PERSONS DISCHARGING MANAGERIAL RESPONSIBILITIES AND PERSONS CLOSELY ASSOCIATED WITH THEM

 1 1.

Details of the person discharging managerial responsibilities/person closely associated

a)

Name:

Robert Ross

1.2 2.

Reason for the notification

a)

Position/status:

CEO

b)

Initial notification/Amendment:

Initial notification

1.3 3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name:

Xpediator Plc

b)

LEI:

213800XBOVDBT2HEC967

1.4 4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the financial instrument, type of instrument:

Identification code:

CSOP options

GB00BF6P5V92

b)

Nature of the transaction:

Grant of options under Company and CSOP

c)

Price(s) and volume(s):

Price(s)

Volume(s)

Nil

67,415

 

 

d)

Aggregated information:

Aggregated volume:

Price:

n/a

 

e)

Date of the transaction:

 

5 February 2021

 

f)

Place of the transaction:

Off market

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
MSCEAFALEEAFEAA
Date   Source Headline
4th Jan 20236:20 pmRNSForm 8.3 - Xpediator plc
4th Jan 20233:14 pmRNSForm 8 (OPD) - Xpediator plc
21st Dec 202210:29 amRNSForm 8.3 - Xpediator plc
20th Dec 202211:05 amRNSSecond Price Monitoring Extn
20th Dec 202211:00 amRNSPrice Monitoring Extension
20th Dec 20229:41 amRNSForm 8.3 - Xpediator plc
20th Dec 20227:00 amRNSAnnouncement regarding possible offer
3rd Nov 20227:00 amRNSQ3 Trading Update
27th Sep 20229:05 amRNSSecond Price Monitoring Extn
27th Sep 20229:00 amRNSPrice Monitoring Extension
26th Sep 20227:00 amRNSHalf-year Report
20th Sep 20227:00 amRNSNotice of Interim Results & Investor Presentation
10th Jun 202212:56 pmRNSResult of AGM
9th Jun 20227:00 amRNSAGM Statement
1st Jun 20227:00 amRNSBoard updates
17th May 20228:15 amRNSNotice of AGM
17th May 20227:00 amRNSDirectorate Change
4th Apr 20227:00 amRNSFinal Results
28th Mar 20227:00 amRNSNotice of Results
25th Mar 20224:17 pmRNSDirectorate Change
31st Jan 20227:00 amRNSTrading Update
19th Jan 20227:00 amRNSChange of Adviser
17th Jan 20227:00 amRNSNew Warehouse
22nd Nov 20211:00 pmRNSDirectorate Change
13th Sep 20217:00 amRNSInterim Results
8th Sep 20217:00 amRNSNotice of Results
6th Aug 20217:00 amRNSStrategic Partnership
6th Jul 20217:00 amRNSExercise of Warrants
25th Jun 20217:00 amRNSTrading Statement
8th Jun 20213:30 pmRNSResult of AGM
8th Jun 20217:00 amRNSAGM Statement
25th May 20217:00 amRNSUpdated Ex-Dividend and Record Dates
12th May 20217:00 amRNSPosting of Annual Report and Notice of AGM
12th Apr 20217:00 amRNSFinal Results
7th Apr 20217:00 amRNSNotice of Results and Investor Presentation
3rd Mar 20217:00 amRNSDirector/PDMR Shareholding
19th Feb 202111:05 amRNSSecond Price Monitoring Extn
19th Feb 202111:00 amRNSPrice Monitoring Extension
5th Feb 20217:00 amRNSLaunch of CSOP and Issue of awards to Director
29th Jan 202111:06 amRNSSecond Price Monitoring Extn
29th Jan 202111:00 amRNSPrice Monitoring Extension
29th Jan 20217:00 amRNSTrading Statement
19th Jan 20217:00 amRNSDirectorate Change
31st Dec 20207:00 amRNSDisposal
1st Dec 20207:00 amRNSInvestor Presentation
23rd Nov 20207:00 amRNSTrading Statement
10th Nov 20204:41 pmRNSSecond Price Monitoring Extn
10th Nov 20204:36 pmRNSPrice Monitoring Extension
6th Oct 20207:00 amRNSAcquisition
1st Oct 20207:00 amRNSDirectorate Change

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.